TWi Must Pay Fees After Ignoring Court Warnings In IP Row
TWi Pharmaceuticals must foot part of Supernus Pharmaceuticals' legal bills after relying on a position that was "squarely at odds with the evidence presented" at a patent infringement trial, a New...To view the full article, register now.
Already a subscriber? Click here to view full article